Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis

Anticancer Research

Volumn 19, Issue 5 B, 1999, Pages 3953-3959

  Büssing, Arndt ^a,c   Stein, G M ^a   Stumpf, C ^b   Schietzel, M ^b  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b Herdecke Community Hospital   (Germany)

^c University Herdecke   (Germany)

Author keywords

Activation markers; Apoptosis; Chronic lymphocytic leukaemia; Interleukin 6; Proliferation; Viscum album L. extracts

Indexed keywords

CD71 ANTIGEN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; POKEWEED MITOGEN;

ADULT; AGED; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DEATH; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; VISCUM ALBUM;

EID: 0344339126     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Dighiero G, Travade P, Chevret S, Fenaux P, Chastang C, Binet JL, and the Frensh Cooperative Group on CLL: B-cell chronic lymphocytic leukemia: Present status and future directions. Blood 78: 1901-1914, 1991.
2. Hoffbrand AV, Panayiotidis P, Reittie J, Ganeshaguru K: Autocrine and paracrine growth loops in chronic lymphocytic leukemia. Sem Hematol 30: 2981-2989, 1993.
3. Jewell AP: Interferon-alpha, Bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 21: 43-47, 1996.
4. Jewell AP, Lydyard PM, Worman CP, Giles FJ, Goldstone AH: Growth factors can protect B-chronic lymphocytic leukaemia cells against programmed cell death without stimulating proliferation. Leuk Lymphoma 18: 159-162, 1995.
5. Mainou-Fowler T, Prentice AG: Modulation of apoptosis with cytokines in B-cell chronic lymphocyticleukaemia. Leuk Lymphoma 21: 369-377, 1996.
6. Tangye SG, Raison RL: Human cytokines suppress apoptosis of leukaemic CD5+ B cells and preserve expression of bcl-2. Immunol Cell Biol 75: 127-135, 1997.
7. Aderka D, Maor Y, Novick D, Engelmann H, Kahn Y, Levo Y, Wallach D, Revel M: Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukaemia cells that is induced by tumor necrosis factor-α or -β. Blood 81: 2076-2084, 1993.
8. van Kooten C, Rensink I, Aarden L, van Oers R: Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leulemia cells. Leukemia 7: 618-624, 1993.
9. Reittie JE, Hoffbrand AV: Interleukin-4 (IL-4) inhibits proliferation and spontaneous cytokine release by chronic lymphocytic leukaemia cells. Leuk Res 18: 55-60, 1994.
10. Reittie JE, Yong KL, Panayiotidis P, Hoffbrand AV: Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia. Leuk Lymphoma 22: 83-90, 1996.
11. Hirano T, Kishimoto T: Interleukin-6: possible implications in human diseases. Ric Clin Lab 19: 10, 1989.
12. Burger R, Wendler J, Antoni K, Helm G, Kalden JR, Glamatzki M: Interleukin-6 production in cell neoplasias and Castleman's disease - evidence for an additional paracrine loop. Ann CHematol 69: 25-31, 1994.
13. Janssen O, Scheffler A, Kahelitz D: In vitro effects of mistletoe extlacts and mistletoe lectins. 'Cytotoxicity towards tumour cells due to the induction of programmed cell death (apoptosis). Arzneim Forsch/Drug Res 43: 1221-1227, 1993.
14. Büssing A, Suzart K, Bergmann J, Pfüller U, Schietzel M, Schweizer K: Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer Lett 99: 59-72, 1996.
15. Büssing A: Induction of apoptosis by the mistletoe lectins. A review on the mechanisms of cytotoxicity mediated by Viscum album L. Apoptosis 1: 25-32, 1996.
16. Büssing A, Stein GM, Pfüller U: Selective killing of CD8+ cells with a 'memory' phenotype (CD62LT) by trie N-acetyl-galactosamine-specific lectin from Viscum album L. Cell Death Diff 5: 231-240, 1998.
17. Büssing A, Multani AS, Pathak S, Pfüller U, Schietzel M: Induction of apoptosis by the N- acetyl-galactosamine-specific toxic lectin fiom Viscum album L. is associated with a decrease of nuclear p53 and Bcl-2 proteins and an induction of chromosomal affections. Cancer Lett 130: 57-68, 1998.
18. Hajto T, Hostanska K, Frey K, Rordorf C, Gabius HJ: Increased secretion of tumor necrosis factor a. interleukin 1, and interleukin 6 by human mononuclear cells exposed to β-galactoside- specific lectin from clinically applied mistletoe extract. Cancer Res 50: 3322-3326, 1990.
19. Joller PW, Menrad JM, Schwarz T, Pfuller U, Parnham MJ, Weyhenmeyer R, Lentzen H: Stimulation of cytokine production via a special standardized mistletoe preparation in an in vitro human skin bioassay. Arzneim Forsch/Drug Res 46: 649-653, 1996.
20. Ribereau-Gayon G, Dumont S, Muller C, Jung ML, Poindron P, Anton R: Mistletoe lectins I, II, and III induce the production of cytokines by cultured human monocytes. Cancer Lett 109: 33-38, 1996.
21. Hostanska K, Hajto T, Spagnoli GC, Fischer J, Lentzen H, Herrmann R: A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells. Nat Immun 14: 295-304, 1996.
22. Stein GM, Meink H, Durst J, Berg PA: Release of cytokines by a fermented mistletoe lectin-1 (free mistletoe extract reflects differences in the reactivity of PBMC in healthy individuals and tumor patients. Eur J Clin Pharmacol 51: 247-252, 1996.
23. Stein GM, Henn W, von Laue B, Berg PA: Modulation of the cellular and humoral immune responses oftumor patients during mistletoe therapy. Eur J Med Res. 3: 194-202, 1998.
24. Stein GM, Berg PA: Modulation ofthe cellular and humoral immune responses during mistletoe treatment in healthy individuals. Eur J Med Res 3: 307-314, 1998.
25. Cheson B: Chronic lymphocytic leukemia. In: Current Therapy in Cancer, eds., Foley JF, Vose JM, Armitage, Philadelphia, London, Toronto, Montreal, Sydney, Tokyo, W.B. Saunders Company, pp. 327-330, 1994.
26. Carayon P, Bord A: Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNA. J Immunol Meth 147: 225-230, 1992.
27. Danescu M, Rubio-Trujillo M, Biron G, Bron D, Delespesse G, Sarfati M: Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression. J Exp Med 176: 1319-1326, 1992.